FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Walter Matthew R.
2. Date of Event Requiring Statement (Month/Day/Year)
06/24/2024		 3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [MDT]
(Last)
(First)
(Middle)
710 MEDTRONIC PARKWAY		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP, Chief HR Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)

MINNEAPOLIS, MN 55432		 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Ordinary Shares 16,788 (1) (2)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(Month/Day/Year) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) 07/28/2015(3) 07/28/2024 Ordinary Shares 492 $ 62.76 D  
Stock Option (Right to Buy) 01/27/2016(3) 01/27/2025 Ordinary Shares 1,337 $ 74.84 D  
Stock Option (Right to Buy) 08/03/2016(3) 08/03/2025 Ordinary Shares 1,283 $ 78 D  
Stock Option (Right to Buy) 08/01/2017(3) 08/01/2026 Ordinary Shares 1,704 $ 88.06 D  
Stock Option (Right to Buy) 07/31/2018(3) 07/31/2027 Ordinary Shares 1,787 $ 83.97 D  
Stock Option (Right to Buy) 07/30/2019(3) 07/30/2028 Ordinary Shares 2,542 $ 89.08 D  
Stock Option (Right to Buy) 10/29/2019(3) 10/29/2028 Ordinary Shares 191 $ 89.45 D  
Stock Option (Right to Buy) 07/29/2020(3) 07/29/2029 Ordinary Shares 5,330 $ 103.26 D  
Stock Option (Right to Buy) 08/03/2021(3) 08/03/2030 Ordinary Shares 7,652 $ 97.33 D  
Stock Option (Right to Buy) 08/02/2022(3) 08/02/2031 Ordinary Shares 6,944 $ 131.26 D  
Stock Option (Right to Buy) 08/01/2023(3) 08/01/2031 Ordinary Shares 9,908 $ 93.08 D  
Stock Option (Right to Buy) 07/31/2024(3) 07/31/2033 Ordinary Shares 24,525 $ 87.76 D  
Performance Share Unit   (4)   (4) Ordinary Shares 677 (5) $ (6) D  
Performance Share Unit   (7)   (7) Ordinary Shares 2,828 (8) $ (6) D  
Performance Share Unit   (9)   (9) Ordinary Shares 8,449 (10) $ (6) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Walter Matthew R.
710 MEDTRONIC PARKWAY
MINNEAPOLIS, MN 55432		       SVP, Chief HR Officer  

Signatures

/s/ Thomas L. Osteraas, attorney-in-fact 07/02/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 1,196 shares purchased pursuant to the Employee Stock Purchase Plan.
(2) Includes 745 restricted stock units that vest on August 2, 2024; 104 restricted stock units that vest on May 2, 2025; 1,140 restricted stock units that vest on August 1, 2025; 104 restricted stock units that vest on May 2, 2026; and 3,380 restricted stock units that vest on July 31, 2026.
(3) These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
(4) The performance share units vest on August 2, 2024.
(5) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 677 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
(6) Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
(7) The performance share units vest on August 1, 2025.
(8) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,828 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
(9) The performance share units vest on July 31, 2026.
(10) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,449 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.